S'abonner

Efficacy of bolus-dose epinephrine to manage hypotension in the prehospital setting - 30/11/21

Doi : 10.1016/j.ajem.2021.07.006 
Kyle A. Weant, PharmD a, , David M. French, MD b
a Department of Clinical Pharmacy and Outcome Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, USA 
b Department of Emergency Medicine, Trident Health Medical Center, Charleston, SC, USA 

Corresponding author at: Department of Clinical Pharmacy and Outcome Sciences, College of Pharmacy, University of South Carolina, 316A Coker Life Sciences Building, Columbia, SC 29208, USA.Department of Clinical Pharmacy and Outcome SciencesCollege of PharmacyUniversity of South Carolina316A Coker Life Sciences BuildingColumbiaSC29208USA

Abstract

Purpose

Hypotension in the Emergency Department (ED) and the prehospital setting has been associated with significant morbidity and mortality. Limited literature exists exploring the utilization of intravenous (IV) bolus-dose epinephrine (BDE) by Emergency Medical Services (EMS).

Methods

A retrospective review evaluated patients transported to an academic medical center who had received IV BDE by a single urban EMS system from 2016 to 2020. The primary outcome was to assess the influence IV BDE had on systolic blood pressure (SBP). Secondary objectives were to assess changes in heart rate (HR), the impact of dose variability on SBP, and the incidence of severe hypertension (SBP > 220 mmHg).

Results

A total of 55 patients who received 96 administrations of IV BDE were included in the analysis. The most common individual dose was 10 μg (76.0%) and 45.5% received multiple doses. The median weight-based dose of BDE was 0.14 μg/kg. A significant increase in SBP (median 14.0 mmHg) was noted among all patients following BDE administration compared with baseline (p < 0.001). No significant difference was found in HR following BDE compared with baseline (p = 0.375). Those that received a BDE dose >10 μg were noted to have a significantly greater rise in SBP than those that received 10 μg (30.0 mmHg vs. 11.0 mmHg; p = 0.022). Similarly, patients that received a dose ≥0.2 μg/kg had a significantly greater increase in SBP compared with those that received <0.2 μg/kg (30.0 mmHg vs. 10.0 mmHg; p = 0.048). There were no incidences of severe hypertension following therapy.

Conclusion

The utilization of IV BDE in the prehospital setting for acute hypotension resulted in a significant rise in SBP. A dose-response relationship was noted both in terms of a flat-based dose and a weight-based dose, with higher doses yielding a greater change in SBP. Additional investigations are necessary to further explore the most appropriate dose of this agent in this setting and its influence, if any, on clinical outcomes.

Le texte complet de cet article est disponible en PDF.

Keywords : Epinephrine, Emergency medical services, Emergency service, Hypotension, Prehospital

Abbreviations : ED, IV, BDE, EMS, SBP, DBP, HR, MAP


Plan


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 50

P. 71-75 - décembre 2021 Retour au numéro
Article précédent Article précédent
  • Effect of Guo Qing Yi Tang combined with Western medicine cluster therapy on acute pancreatitis
  • Ying-Jie Chen, Ming-Zhi Chen, Hong-Wei Zhang, Gui-Song Wu, Sen-Ren Guo
| Article suivant Article suivant
  • Effect of focused protocol on reducing radiation dose for children who require computed tomography for suspected appendicitis
  • Suzanne Roberts, Bernard Goldwasser, Abigail F Nixon, Deeksha Borkar, Max Brookman, Carolyn E. Fox, Cyril Rosenfeld, James A Meltzer

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.